Media
Explore our latest news, events, and resources.
From educational publications to campaign highlights and upcoming activities, this section brings together all our updates to keep patients, healthcare professionals, and advocates informed and engaged in the world of radioligand therapy.
News
- News07.05.2021
Travel cards could help radiopharma patients avoid delays
Read more - News30.04.2021
PSMA theranostic Lu-177-PSMA-617 approaches prime time in mCRPC
Read more - News20.04.2021
Noble Registry - iPSMA SPECT Imaging for Prostate Cancer
Read more - News16.04.2021
Doctor, What is Neuroendocrine Cancer?
Read more - News13.04.2021
How Nuclear Technology can Beat Cancer
Read more - News09.04.2021
Seeing Cancer Cells, Killing Cancer Cells
Read more
Events
- EventsJune 11-14, 2022
SNMMI 2022 Annual Meeting
Read more - Events30 May 2022
May 30 - Webinar - PSMA PET/CT Beyond the Images
Read more - Events13-15 May 2022
ANZSNM 2022 - Brisbane, Australia
Read more - Events6 May 2022
8th International Symposium on Medical Radioisotopes
Read more - EventsNovember 17 & 18, 2021
European Cancer Summit 2021
Read more - EventsOctober 20-23, 2021
EANM 2021 - VIRTUAL
Read more
Videos
What Are Radiotheranostics for Cancer Care?
Doctor, will Radiotheranostics make me radioactive?
Tom, treated with PRRT for NETs
Fernando Acosta’s Testimonial with Lutetium-177 PSMA Radioligand Therapy
Links
Nuclear medicine
- The NME (Nuclear medicine Europe) has implemented a website for the general public called “What is Nuclear medicine ?”, that features movies, cartoons and special small booklets to be downloaded that explain basic concepts.
- Official bodies such as EANM and SNMMI also have materials explaining aria-describedby="qtip-67">Nuclear medicine.
- You will find useful information as well on the IAEA website about Radiopharmaceuticals production and some interesting Publications regarding advances search.
Books
In order to explain this technology in an accessible way, a reference booklet containing information on Nuclear medicine was written by the author of this project. It was initially intended for workers in the Radiopharmaceutical industry but was then used for patients and finally distributed to potential investors. This book is presently available in French, English, and Spanish.